DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kopetz S. et al.
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
J Clin Oncol 2015;
33: 4032-4038
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.